NYSE:MEDPersonal Products
Medifast (MED) Q4 Loss Deepens Bearish Narratives On Earnings Sustainability
Medifast (MED) closed out FY 2025 with Q4 revenue of US$75.1 million and a basic EPS loss of US$1.65, alongside a trailing twelve month EPS loss of US$1.70 on revenue of US$385.8 million. Over the last six reported quarters, revenue has moved from US$140.2 million in Q3 2024 to US$75.1 million in Q4 2025, while quarterly EPS has ranged from a profit of US$0.23 in Q2 2025 to a loss of US$1.65 in Q4 2025. With the stock at US$10.71, the latest print keeps the focus firmly on pressure at the...